Globe Newswire
CALGARY, Alberta, July 31, 2026 (GLOBE NEWSWIRE) --
TransAlta Corporation (TransAlta or the Company) (TSX: TA) (NYSE: TAC) today reported its financial results for the second quarter ended June 30, 2026.
“TransAlta delivered strong operational performance across our portfolio in the second quarter, underlining our ability to generate reliable free cash flow from our diversified fleet despite a challenging Alberta market and reduced market volatility," said Joel... (continue reading...)
MALVERN, Pa., July 31, 2026 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that the Company will present on its innovative modifier gene therapy platform at upcoming investor conferences in August 2026.
Oppenheimer 4th Annual Biotech in the Berkshires Summit
Location: Miraval Resort, Lenox, MADate: Tuesday, August 4, 2026Time: 12:30–1:10 p.m.... (continue reading...)
SINGAPORE, July 31, 2026 (GLOBE NEWSWIRE) -- GCL Global Holdings Ltd. (NASDAQ: GCL) (“GCL” or the “Company”), a leading provider of games and entertainment, today announced its financial results for the year ended March 31, 2026.
FY2026 Highlights
- Revenues of $238.9 million, up 68.2% from the prior year period
- Gross Margin of 10.3% compared to 15.0% in fiscal year 2025
- Net loss of $26.2 million, compared to net income of $5.0 million in the same period last year
- EBITDA... (continue reading...)
TORONTO, July 31, 2026 (GLOBE NEWSWIRE) -- George Weston Limited (TSX: WN) (“GWL” or the “Company”) today announced its consolidated unaudited results for the 12 weeks ended June 20, 2026(2).
GWL’s 2026 Second Quarter Report has been filed on SEDAR+ and is available at www.sedarplus.ca and in the Investor Centre section of the Company’s website at www.weston.ca.
“George Weston delivered strong second quarter results, driven by the continued momentum of its operating... (continue reading...)
Reported positive results from the Phase 2b clinical trial of imaging agent RAD 101, showing 93% of evaluable patients treated with RAD 101 achieved the primary endpoint
Plans to initiate Phase 3 registrational trial of RAD 101 in Q4 2026
Raised approximately $12.5M through an institutional offer and launched a $6million Share Purchase Plan, post balance date
SYDNEY, July 31, 2026 (GLOBE NEWSWIRE) -- Radiopharm Theranostics (ASX: RAD, Nasdaq: RADX, “Radiopharm”... (continue reading...)
More Globe Newswire
View Older Stories-
The Orange Giant Announces ZHAI Has Entered Full Production
-
Tenax Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
-
Werewolf Therapeutics Reports Second Quarter 2026 Financial Results and Recent Corporate Updates
-
INmune Bio Receives R&D Rebates of Approximately $4.6 Million
-
Tiziana Reports Reduction in Brain Inflammation in Third Multiple System Atrophy Patient Treated with Intranasal Foralumab
-
Balchem Corporation Reports Second Quarter 2026 Financial Results
-
LEO Technologies Launches Verus ION, an Agentic AI-Powered Unified Intelligence and Investigative Solution for Corrections and Public Safety
-
Regeneron Awards $150,000 to Winners of the 2026 Regeneron Prize for Creative Innovation
-
INmune Bio Receives R&D Rebates of Approximately $4.6 Million
-
Green Thumb Expands Pennsylvania Retail Footprint with the Opening of RISE Dispensary Hanover
-
American Tungsten Corp. Begins Trading on OTCQX Best Market
-
INmune Bio Inc. to Report Second Quarter 2026 Financial Results and Provide Corporate Update on Thursday, August 6th
-
Perella Weinberg Announces Partner Promotions
-
Perella Weinberg Reports Second Quarter 2026 Results
-
Brookfield Renewable Reports Strong Second Quarter Results
-
Bullish to announce second quarter 2026 financial results
-
Vireo Growth Inc. Announces a Four-Deal Transaction to Establish Presence in Ohio
-
Brookfield Business Corporation Reports Strong Second Quarter 2026 Results
-
Veridas Consolidated as a Visionary in the 2026 Gartner® Magic Quadrant™ for Identity Verification for Second Consecutive Year
-
nVent Electric plc Second Quarter 2026 Financial Results Available on Company’s Website
-
LyondellBasell reports second quarter 2026 earnings
-
Perspective Therapeutics to Provide Business Highlights and Report Second Quarter 2026 Financial Results
-
LAF Technology Launches RailFlex™ Railway Flexitank Series for Cross-Border Bulk Liquid Transportation
-
Italfarmaco Announces Managed Entry Agreement in Georgia for Givinostat as Treatment for Patients with Duchenne Muscular Dystrophy
-
FERRARI N.V.: PERIODIC REPORT ON THE BUYBACK PROGRAM
-
nVent Expands Data Center Liquid Cooling Capacity
-
Form 8.5 (EPT/RI)-Gamma Communications Plc
-
Storaktionærmeddelelse
-
Form 8.5 (EPT/RI)-Advanced Medical Solutions Group Plc
-
Form 8.5 (EPT/NON-RI)-Gamma Communications Plc
-
Costamare Bulkers Holdings Limited Sets the Date for Its Second Quarter 2026 Results Release
-
JD.com to Report Second Quarter and Interim 2026 Financial Results on August 13, 2026
-
Perimeter Solutions Reports Second Quarter 2026 Financial Results
-
Fortis Inc. Releases Second Quarter 2026 Results
-
BrightSpring Health Services, Inc. Reports Second Quarter 2026 Financial Results and Increases Full Year 2026 Guidance
-
Titan Mining to Host Q2 2026 Update Call on August 12, 2026
-
Patria Reports Second Quarter 2026 Earnings Results
-
Form 8.3 - LondonMetric Property plc
-
ICODA CBDO Artem Voinov Attend Blockchain Rio 2026 as Latin America Strengthens Its Position in Global Web3 Growth
-
Man Group PLC : Form 8.3 - Senior plc
-
Net Asset Value
-
Man Group PLC : Form 8.3 - Gamma Communications Plc
-
Performa Marks One Year Live with Major Upgrade for Digital-Native SMBs
-
AS Tallinna Vesi held an investor conference webinar to introduce the results of the second quarter of 2026
-
Magna Announces Strong Second Quarter Results; Raises Outlook for 2026
-
CSG Builds Czech Technology Centre for AviaNera’s Advanced UAS Propulsion Systems
-
Holding(s) in Company
-
iQIYI to Report Second Quarter 2026 Financial Results on August 18, 2026
-
Results of ING’s Extraordinary General Meeting
-
Form 8.5 (EPT/RI) - Pharos Energy Plc

